13D/13G Filings - OCULAR THERAPEUTIX INC (OCUL)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-01-31
8:38 pm
Sale
2021-12-31 13G Ocular Therapeutix, Inc.
OCUL
Opaleye Management Inc. 5,974,800
7.800%
-535,200decrease
(-8.22%)
Filing
History
2021-02-12
5:20 pm
Purchase
2020-12-31 13G Ocular Therapeutix, Inc.
OCUL
Opaleye Management Inc. 6,510,000
8.650%
1,384,000increase
(+27.00%)
Filing
History
2021-02-02
3:13 pm
Purchase
2020-12-31 13G Ocular Therapeutix, Inc.
OCUL
BlackRock Inc.
BLK
5,512,264
7.300%
2,506,097increase
(+83.37%)
Filing
History
Goto Prev, 0, 1